new thread, page-3

Hard to see what will stop the selling.Its been constant for a few months.

The company to my mind does not seem all that confident of INTUBE approval any time soon which begs the question whats the delay.The submission did not even have to front the FDA panel but still we wait.

As for the share price we could go back thru $3.00 if the current selling continues unless we get some buying from the instos which forked out $8 mill at $3.20 some time back.

Might be a long painful wait for next quarters figures.Lets hope the company does not publish any more dodgy sales graphs.

Regards,